An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer

Alastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, +29

Nature Cell Biology

UrologyHormonal ReceptorGynecologyProstatic DiseaseMedicine +2

ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer

Shaghayegh Nouruzi, Dwaipayan Ganguli, Nakisa Tabrizian, +9

Nature Communications

Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma

Takeshi Namekawa, Takanobu Utsumi, Koji Kawamura, +8

Surgery

Adrenal GlandEndocrine DiseaseProlonged Postresection HypotensionEndocrine SurgerySurgery +5

ALDH1A1 in patient‐derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression

Takeshi Namekawa, Kazuhiro Ikeda, Kuniko Horie‐Inoue, +6

International Journal of Cancer

Tumor BiologyUrologyOncologyTubb3 OverexpressionMedicine +13

Analysis of Preoperative Detection for Apex Prostate Cancer by Transrectal Biopsy

Tomokazu Sazuka, Takashi Imamoto, Takeshi Namekawa, +9

Prostate Cancer

Therapeutic outcomes of neoadjuvant and concurrent androgen‐deprivation therapy and intensity‐modulated radiation therapy with gold marker implantation for intermediate‐risk and high‐risk prostate cancer

Masayuki Kobayashi, Kazuo Hatano, Satoshi Fukasawa, +7

International Journal of Urology

Prospective evaluation of the safety of transrectal ultrasound-guided transperineal prostate biopsy based on adverse events

Takeshi Namekawa, Satoshi Fukasawa, Atsushi Komaru, +8

International Journal of Clinical Oncology

Adverse EventsUrologyMedical UltrasoundProspective EvaluationBenign Prostatic Hyperplasia +5

Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma

Shuhei Kamada, Takeshi Namekawa, Kazuhiro Ikeda, +9

Oncogene

Functional InhibitionReceptor Tyrosine KinaseRenal Cell CarcinomaCell BiologyTumor Suppressor +1

RETRACTED: ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer

Nakisa Tabrizian, Shaghayegh Nouruzi, Cassandra Jingjing Cui, +7

Cell Reports

Efficacy of traditional and alternative sunitinib treatment schedules in <scp>J</scp>apanese patients with metastatic renal cell carcinoma

Takayuki Ohzeki, Satoshi Fukasawa, Atsushi Komaru, +7

International Journal of Urology